Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Mapping the Synthetic Biology Industry: Implications for Biosecurity.

Carter S, DiEuliis D.

Health Secur. 2019 Sep/Oct;17(5):403-406. doi: 10.1089/hs.2019.0078. No abstract available.

PMID:
31593512
2.

Does Biotechnology Pose New Catastrophic Risks?

DiEuliis D, Ellington AD, Gronvall GK, Imperiale MJ.

Curr Top Microbiol Immunol. 2019 Aug 30. doi: 10.1007/82_2019_177. [Epub ahead of print]

PMID:
31463535
3.

Biodefense Policy Analysis-A Systems-based Approach.

DiEuliis D, Rao V, Billings EA, Meyer CB, Berger K.

Health Secur. 2019 Mar/Apr;17(2):83-99. doi: 10.1089/hs.2018.0082. Epub 2019 Apr 3.

PMID:
30942632
4.

Erratum for DiEuliis and Gronvall, "A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus".

DiEuliis D, Gronvall GK.

mSphere. 2018 Apr 11;3(2). pii: e00160-18. doi: 10.1128/mSphere.00160-18. Print 2018 Apr 25. No abstract available.

5.

A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus.

DiEuliis D, Gronvall GK.

mSphere. 2018 Mar 7;3(2). pii: e00074-18. doi: 10.1128/mSphere.00074-18. eCollection 2018 Mar-Apr. Erratum in: mSphere. 2018 Apr 11;3(2):.

6.

Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity.

DiEuliis D, Giordano J.

Protein Cell. 2018 Mar;9(3):239-240. doi: 10.1007/s13238-017-0493-4. No abstract available.

7.

Biosecurity Implications for the Synthesis of Horsepox, an Orthopoxvirus.

DiEuliis D, Berger K, Gronvall G.

Health Secur. 2017 Nov/Dec;15(6):629-637. doi: 10.1089/hs.2017.0081. Epub 2017 Nov 1.

PMID:
29091742
8.

Options for Synthetic DNA Order Screening, Revisited.

DiEuliis D, Carter SR, Gronvall GK.

mSphere. 2017 Aug 23;2(4). pii: e00319-17. doi: 10.1128/mSphere.00319-17. eCollection 2017 Jul-Aug.

9.

Why Gene Editors Like CRISPR/Cas May Be a Game-Changer for Neuroweapons.

DiEuliis D, Giordano J.

Health Secur. 2017 May/Jun;15(3):296-302. doi: 10.1089/hs.2016.0120. Epub 2017 Jun 2.

10.

The Department of Defense Chemical and Biological Defense Program: An Enabler of the Third Offset Strategy.

Roos J, Chue C, DiEuliis D, Emanuel P.

Health Secur. 2017 Mar/Apr;15(2):207-214. doi: 10.1089/hs.2017.0008. Epub 2017 Apr 7.

PMID:
28388218
11.

Opinion: Specimen collections should have a much bigger role in infectious disease research and response.

DiEuliis D, Johnson KR, Morse SS, Schindel DE.

Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):4-7. doi: 10.1073/pnas.1522680112. No abstract available.

12.

The Role of Scientific Collections in Scientific Preparedness.

DiEuliis D.

Emerg Infect Dis. 2015 Aug;21(8). doi: 10.3201/eid2108.150423. No abstract available.

13.

A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.

Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, Elliott RA, Shoulson I.

Mov Disord. 2014 May;29(6):743-9. doi: 10.1002/mds.25814. Epub 2014 Feb 11.

14.

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.

Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators.

Mov Disord. 2009 Oct 30;24(14):2081-90. doi: 10.1002/mds.22690.

PMID:
19691116
15.

Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.

Cole NB, Dieuliis D, Leo P, Mitchell DC, Nussbaum RL.

Exp Cell Res. 2008 Jun 10;314(10):2076-89. doi: 10.1016/j.yexcr.2008.03.012. Epub 2008 Mar 28.

16.

Retrograde transport of Golgi-localized proteins to the ER.

Cole NB, Ellenberg J, Song J, DiEuliis D, Lippincott-Schwartz J.

J Cell Biol. 1998 Jan 12;140(1):1-15.

Supplemental Content

Loading ...
Support Center